In agreement with the oncogenic functions of METTL3 in HCC, similar observations have recently been reported in several other types of cancer, namely, AML (30), GMB (31), bladder cancer (32), gastric cancer (33), and breast cancer (34). Here, METTL3 is linked to urinary bladder carcinoma.